Evidence map›Paper›PMID 30828744›Full record

ArticleEuropean child & adolescent psychiatry2019

Childhood methylphenidate adherence as a predictor of antidepressants use during adolescence.

Nir Madjar, Dan Shlosberg, Maya Leventer-Roberts, Amichay Akriv, Adi Ghilai, Moshe Hoshen, Amir Krivoy, Gil Zalsman, Gal Shoval

Abstract read
PubMed Publisher
In one paragraph

Article in European child & adolescent psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Association between Attention Deficit Hyperactivity Disorder Medication and Depression: A 10-year Follow-up Self-controlled Case Study.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Nir MadjarFaculty of Social Sciences, School of Education, Bar-Ilan University, 5290002, Ramat Gan, Israel. nir.madjar@biu.ac.il.ORCID http://orcid.org/0000-0002-4931-8904
Dan ShlosbergClalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Maya Leventer-RobertsClalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Amichay AkrivClalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Adi GhilaiClalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Moshe HoshenClalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Amir KrivoyGeha Mental Health Center, Petah Tikva, Israel.
Gil ZalsmanGeha Mental Health Center, Petah Tikva, Israel.
Gal ShovalGeha Mental Health Center, Petah Tikva, Israel.
Clalit Health Services · ILTel Aviv University · ILBar-Ilan University · ILGeha Mental Health Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylphenidate (MPH) is a common and effective treatment for attention deficit hyperactivity disorder (ADHD), but little is known about the relationship between early childhood intake of MPH and onset of antidepressant treatment during adolescence. The study aimed to examine whether adherence to MPH during early childhood predicts the initiation of antidepressants during adolescence. This is a 12-year historical prospective nationwide cohort study of children enrolled in an integrated care system who were first prescribed MPH between the ages of 6 and 8 years (N = 6830). We tested for an association between their adherence to MPH during early childhood (as indicated by medication possession ratio from MPH onset through the age of twelve) and the likelihood of being prescribed any antidepressant during adolescence (age 13-18). As all country citizens are covered by mandatory health insurance, and full services are provided by one of the four integrated care systems, data regarding patients' diagnoses, prescriptions, and medical purchases are well documented. Logistic regression analysis indicated that those with higher adherence to MPH had a 50% higher risk (95% CI 1.16-1.93) of receiving antidepressants during adolescence when controlling for other comorbid psychiatric conditions and parental use of antidepressants. In this large-scale longitudinal study, MPH adherence during early childhood emerged as a predictor for antidepressant treatment during adolescence, which may reflect increased emotional and behavioral dysregulation in this group. The highly adherent patients are at higher risk and should be clinically monitored more closely, particularly into adolescence.

Indexed as

Antidepressive AgentsCentral Nervous System StimulantsChildCohort StudiesDepressionFemaleHumansLongitudinal StudiesMaleMethylphenidateProspective StudiesTreatment OutcomeAntidepressive AgentsCentral Nervous System StimulantsMethylphenidateAdherenceAntidepressantsAnxietyAttention deficit hyperactivity disorderDepressionLongitudinal analysisMethylphenidate

Identifiers

PMID30828744
OpenAlexW2919615198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.